MICHELLE MIRASGELDI: Open Payments
NPI 1306545512 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 11 payments from 8 companies in 2025. Trend: 2023 $47 · 2024 $142 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $41 |
| Acella Pharmaceuticals, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Seqirus USA Inc | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Renalytix AI, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: NP Thyroid 60, FARXIGA, ZEPBOUND, MOUNJARO, Fluad, Ozempic, LAGEVRIO, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across NJ — which companies pay providers there.
